Biogen Soars 46% on Alzheimer’s Drug Trial. Mizuho Says the Stock Is a Buy. | Barron’s
Biogen Soars 46% on Alzheimer’s Drug Trial. Mizuho Raises the Stock to Buy.
the close up of the five rows coins ,and the coins jar that fell, with the back ground is a dark blue graph.
